These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 10166232)
41. [Efficacy and safety of clarithromycin in the treatment of community-acquired pneumonia]. Parola D; Dell'Orso D; Terzano C Recenti Prog Med; 2000 Jan; 91(1):12-5. PubMed ID: 10705778 [TBL] [Abstract][Full Text] [Related]
42. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Frank MO; Batteiger BE; Sorensen SJ; Hartstein AI; Carr JA; McComb JS; Clark CD; Abel SR; Mikuta JM; Jones RB Clin Perform Qual Health Care; 1997; 5(4):180-8. PubMed ID: 10176026 [TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness in the use of antibiotics. McNabb J; Quintiliani R; Nicolau DP; Grant E; Nightingale CH Curr Clin Top Infect Dis; 2000; 20():24-42. PubMed ID: 10943517 [No Abstract] [Full Text] [Related]
47. Implementation of intravenous to oral antibiotic switch therapy guidelines in the general medical wards of a tertiary-level hospital in South Africa. van Niekerk AC; Venter DJ; Boschmans SA J Antimicrob Chemother; 2012 Mar; 67(3):756-62. PubMed ID: 22167244 [TBL] [Abstract][Full Text] [Related]
48. A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis. Ballock RT; Newton PO; Evans SJ; Estabrook M; Farnsworth CL; Bradley JS J Pediatr Orthop; 2009 Sep; 29(6):636-42. PubMed ID: 19700997 [TBL] [Abstract][Full Text] [Related]
49. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of an antibiotic intravenous to oral sequential therapy program. Pablos AI; Escobar I; Albiñana S; Serrano O; Ferrari JM; Herreros de Tejada A Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):53-9. PubMed ID: 15534901 [TBL] [Abstract][Full Text] [Related]
51. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community]. Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168 [TBL] [Abstract][Full Text] [Related]
54. Iv antibiotic therapy in an outpatient setting: report of a joint venture program. Eron LJ Hosp Formul; 1988 May; 23(5):440-2, 447. PubMed ID: 10312485 [TBL] [Abstract][Full Text] [Related]
55. [Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia treated at home and nosocomial pneumonia]. Boersma WG; Jansen HM Ned Tijdschr Geneeskd; 1998 Jul; 142(30):1741-2. PubMed ID: 9763873 [No Abstract] [Full Text] [Related]
56. Observing patients after antibiotics are discontinued. Farber BF; Cooper DJ N Engl J Med; 1995 Oct; 333(16):1083-4. PubMed ID: 7675069 [No Abstract] [Full Text] [Related]
57. Oral ciprofloxacin versus intravenous antibiotics. Lang SD Pharmacoeconomics; 1992 Jul; 2(1):87-8. PubMed ID: 10147115 [No Abstract] [Full Text] [Related]
58. Sequential therapy in the hospital management of lower respiratory infections. Vogel F Am J Med; 1995 Dec; 99(6B):14S-19S. PubMed ID: 8585551 [TBL] [Abstract][Full Text] [Related]
59. Determining the formulary status of quinolone antibiotics: one institution's approach. Nightingale CH; Lubowski T; On A; Quintiliani R Hosp Formul; 1992 May; 27(5):509-10, 513-4, 516. PubMed ID: 10128710 [TBL] [Abstract][Full Text] [Related]
60. Audit of parenteral antimicrobial agents and infusion fluids. Redding PJ; Taylor A; Smith AM Health Bull (Edinb); 1995 Mar; 53(2):110-4. PubMed ID: 7737872 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]